-+ 0.00%
-+ 0.00%
-+ 0.00%

ENDRA Life Sciences FY 2024 GAAP EPS $(56.94) Misses $(47.46) Estimate

Benzinga·03/31/2025 12:19:36
Listen to the news
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(56.94) per share which missed the analyst consensus estimate of $(47.46) by 19.97 percent.